Gender Differences in Chronic Kidney Disease: Underpinnings and Therapeutic Implications

被引:102
作者
Carrero, Juan Jesus [1 ,2 ,3 ]
机构
[1] Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Ctr Mol Med, Stockholm, Sweden
[2] Karolinska Inst, Div Baxter Novum, Dept Clin Sci Intervent & Technol, Ctr Mol Med, Stockholm, Sweden
[3] Karolinska Inst, Ctr Gender Med, Stockholm, Sweden
关键词
Compliance; Estrogen; Testosterone; HORMONE REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; QUALITY-OF-LIFE; SEX-DIFFERENCES; ARTERIOVENOUS-FISTULA; HEMODIALYSIS-PATIENTS; RISK-FACTORS; POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE;
D O I
10.1159/000320389
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In nephrology, gender differences exist with regard to the epidemiology, evolution and prognosis of chronic kidney disease (CKD). In some cases, these differences run contrary to the general population trends. This review discusses such gender and sex disparities, including differing impact of traditional and novel risk factors, prescription patterns, differences in the responses to therapies, as well as hormonal factors, all of them potentially influencing propensity, progression and biochemical and psychological aspects of CKD. Through the integration of gender aspects in CKD research and management, we may be able not only to identify novel therapeutic targets but also improve existing treatment options. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:383 / 392
页数:10
相关论文
共 120 条
[1]   The relationship between albuminuria and hormone therapy in postmenopausal women [J].
Agarwal, M ;
Selvan, V ;
Freedman, BI ;
Liu, YM ;
Wagenknecht, LE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (06) :1019-1025
[2]   Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy [J].
Ahmed, SB ;
Hovind, P ;
Parving, HH ;
Rossing, P ;
Price, DA ;
Laffel, LM ;
Lansang, MC ;
Stevanovic, R ;
Fisher, NDL ;
Hollenberg, NK .
DIABETES CARE, 2005, 28 (08) :1988-1994
[3]   Oral estrogen therapy in postmenopausal women is associated with loss of kidney function [J].
Ahmed, Sofia B. ;
Culleton, Bruce F. ;
Tonelli, Marcello ;
Klarenbach, Scott W. ;
MacRae, Jennifer M. ;
Zhang, Jianguo ;
Hemmelgarn, Brenda R. .
KIDNEY INTERNATIONAL, 2008, 74 (03) :370-376
[4]   Gender and the renal nitric oxide synthase system in healthy humans [J].
Ahmed, Sofia B. ;
Fisher, Naomi D. L. ;
Hollenberg, Norman K. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (05) :926-931
[5]   Inflammation and wasting in chronic kidney disease: Partners in crime [J].
Avesani, C. M. ;
Carrero, J. J. ;
Axelsson, J. ;
Qureshi, A. R. ;
Lindholm, B. ;
Stenvinkel, P. .
KIDNEY INTERNATIONAL, 2006, 70 :S8-S13
[6]  
BARR SI, 1995, AM J CLIN NUTR, V61, P39
[7]   SEX DIFFERENTIAL IN ISCHEMIC-HEART-DISEASE MORTALITY IN DIABETICS - A PROSPECTIVE POPULATION-BASED STUDY [J].
BARRETTCONNOR, E ;
WINGARD, DL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 118 (04) :489-496
[8]   Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease [J].
Brockenbrough, AT ;
Dittrich, MO ;
Page, ST ;
Smith, T ;
Stivelman, JC ;
Bremner, WJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (02) :251-262
[9]   Venous access: Women are equal [J].
Caplin, N ;
Sedlacek, M ;
Teodorescu, V ;
Falk, A ;
Uribarri, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (02) :429-432
[10]   Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease [J].
Carrero, J. J. ;
Qureshi, A. R. ;
Axelsson, J. ;
Yilmaz, M. I. ;
Rehnmark, S. ;
Witt, M. R. ;
Barany, P. ;
Heimburger, O. ;
Suliman, M. E. ;
Alvestrand, A. ;
Lindholm, B. ;
Stenvinkel, P. .
JOURNAL OF INTERNAL MEDICINE, 2007, 262 (06) :690-701